DarkIris (DKI) restores Nasdaq $1.00 minimum bid compliance after extension

Rhea-AI Filing Summary

DarkIris Inc. reports it has regained compliance with Nasdaq’s minimum bid price requirement. The company had previously fallen below the $1.00 per share threshold under Nasdaq Listing Rule 5550(a)(2) and was given an initial 180-day period, until May 18, 2026, to cure the deficiency.

After not regaining compliance in that first period, DarkIris requested and received an additional 180-day extension to November 16, 2026. Nasdaq later confirmed that, for the 10 consecutive business days from May 12, 2026 through May 26, 2026, the closing bid price of the company’s Class A ordinary shares was at or above $1.00. As a result, Nasdaq determined the company is again in compliance and has closed the matter.

Insights

Equity market and listing standards analyst

DarkIris resolves Nasdaq bid-price deficiency and maintains listing.

DarkIris Inc. had been out of compliance with Nasdaq’s $1.00 minimum bid price rule and was operating under a cure period. It secured an additional 180-day extension to November 16, 2026 after not meeting the requirement in the initial window.

Nasdaq then confirmed the company’s Class A ordinary shares closed at or above $1.00 for 10 consecutive business days, from May 12, 2026 to May 26, 2026. This satisfied Nasdaq Listing Rule 5550(a)(2), so the deficiency proceeding has been closed, reducing near-term delisting risk based on bid price.

Subsequent disclosures in company filings may provide additional context on how the share price behaves relative to the minimum bid threshold over future reporting periods and whether any corporate actions are taken to help maintain compliance.

Key Figures

Initial compliance period: 180 calendar days Extension period: 180-day extension Minimum bid price: $1.00 per share +2 more

5 metrics

Initial compliance period 180 calendar days Period to regain minimum bid compliance until May 18, 2026

Extension period 180-day extension Additional time granted until November 16, 2026

Minimum bid price $1.00 per share Nasdaq Listing Rule 5550(a)(2) requirement

Consecutive trading days at or above $1.00 10 business days From May 12, 2026 through May 26, 2026

Compliance confirmation date range May 12–26, 2026 Period Nasdaq used to confirm restored compliance

Key Terms

Minimum Bid Price Rule, Nasdaq Listing Rule 5550(a)(2), Nasdaq Listing Rule 5810(c)(3)(A), Class A ordinary shares

4 terms

Minimum Bid Price Rule regulatory

"not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Minimum Bid Price Rule”)"

A minimum bid price rule is a stock market requirement that a listed company's share must trade above a set minimum price over a specified period to remain listed on an exchange. It matters to investors because falling below that threshold can trigger warnings, potential delisting, and reduced liquidity—similar to a student needing a passing grade to stay enrolled—making the shares harder to buy, sell, or value accurately.

Nasdaq Listing Rule 5550(a)(2) regulatory

"not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing"

Nasdaq Listing Rule 5810(c)(3)(A) regulatory

"In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days"

Class A ordinary shares financial

"the closing bid price of the Company’s Class A ordinary shares has been at $1.00 per share or greater"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-42795

DarkIris Inc.

(Registrant’s Name)

6/F, Cheong Sun Tower

No. 118 Wing Lok Street

Sheung Wan, Hong Kong

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒                     Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

As previously disclosed, DarkIris Inc. (“Company”) received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated November 18, 2025, notifying the Company that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Minimum Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until May 18, 2026, to regain compliance with Minimum Bid Price Rule. The Company did not regain compliance with the minimum $1.00 bid price per share requirement during the first 180-calendar-day compliance period and submitted a written request to Nasdaq to provide it with an additional 180-day compliance period to cure the deficiency. On May 19, 2025, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day extension, or until November 16, 2026, to regain compliance with the Minimum Bid Price Rule.

On May 27, 2025, Nasdaq provided confirmation to the Company that for the last 10 consecutive business days, from May 12, 2026 through May 26, 2026, the closing bid price of the Company’s Class A ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2), and this matter is now closed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DarkIris Inc.
	By:	/s/ Hong Zhifang
	Name:	Hong Zhifang
	Title:	Chief Executive Officer

Date: May 28, 2026

FAQ

What Nasdaq compliance issue did DarkIris Inc. (DKI) face?

DarkIris Inc. fell out of compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. Nasdaq notified the company of this deficiency and initiated a standard cure period process.

How did DarkIris (DKI) initially respond to the Nasdaq bid price deficiency?

DarkIris received an initial 180-day period, until May 18, 2026, to regain compliance with the $1.00 minimum bid price rule. When it did not cure the deficiency in that window, the company submitted a written request for more time.

Did Nasdaq grant DarkIris Inc. (DKI) more time to regain compliance?

Yes. On May 19, 2025, Nasdaq granted DarkIris an additional 180-day extension to November 16, 2026. This extended period allowed the company more time to restore its share price to the required minimum bid level.

How did DarkIris (DKI) ultimately regain Nasdaq minimum bid price compliance?

Nasdaq confirmed that from May 12, 2026 through May 26, 2026, DarkIris’s Class A ordinary shares closed at $1.00 or higher for 10 consecutive business days. This met the exchange’s minimum bid price requirement under Listing Rule 5550(a)(2).

What is the current status of DarkIris Inc.’s (DKI) Nasdaq listing issue?

After confirming 10 consecutive business days with a closing bid of at least $1.00, Nasdaq determined DarkIris regained compliance with Listing Rule 5550(a)(2). The exchange stated that the bid price deficiency matter is now closed.